Research News

Optimal duration of dual antiplatelet therapy after drug eluting stent remains unclear

BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h2841 (Published 26 May 2015) Cite this as: BMJ 2015;350:h2841
  1. Susan Mayor
  1. 1London

Longer duration of dual antiplatelet therapy after implantation of a drug eluting stent is associated with fewer myocardial infarctions but more major bleeding than a shorter duration, a systematic review has found.

Current guidelines recommend six or 12 months of treatment with aspirin plus a P2Y12 inhibitor (clopidogrel, ticagrelor, or prasugrel) to reduce the risk of stent thrombosis. But the optimal duration of therapy …

View Full Text

Sign in

Log in through your institution

Free trial

Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial

Subscribe